Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective

Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective

Immuno-oncologics (IOs) differ from chemotherapies as they prime the patient’s immune system to attack the tumor, rather than directly destroying cancer cells. The IO mechanism of action leads to durable responses and prolonged survival in some patients. However, providing robust evidence of the lon...

Full description

Saved in:
Bibliographic Details
Main Authors: Phil McEwan, Paolo Antonio Ascierto, Kevin Harrington, Michael B Atkins, Casey Quinn, Louis P Garrison, Anja K Pownell, Gérard de Pouvourville, Samuel Wagner, John Borrill, Elise Wu
Format: Article
Language:English
Published: BMJ Publishing Group 2020-10-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e000648.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items